Procter & Gamble Co. (NYSE:PG) reported third-quarter results that exceeded analyst expectations, with both earnings and revenue surpassing forecasts as the company delivered growth across all business segments.
The company posted adjusted earnings per share of $1.59, beating the consensus estimate of $1.56 by $0.03. Revenue reached $21.2 billion, exceeding the $20.57 billion estimate and increasing 7% year-over-year.
Organic sales, which exclude foreign exchange and acquisitions, grew 3%, driven by a 2% increase in volume and a 1% contribution from pricing.
P&G maintained its full-year fiscal 2026 core EPS guidance of $6.83 to $7.09, with the midpoint of $6.96 slightly above the analyst consensus of $6.94. However, the company indicated that results are expected to trend toward the lower end of the range due to increased investments in innovation and demand creation, as well as pressures from tariffs and commodity costs.
All five segments recorded organic sales growth. The Beauty segment led with a 7% increase, supported by innovation-driven pricing and volume gains. Fabric & Home Care and Baby, Feminine & Family Care each grew 3%, Health Care rose 2%, and Grooming increased 1%.
The company reaffirmed its outlook for full-year organic sales growth ranging from flat to an increase of 4%.
